News und Analysen
T-Mobile to Host Q4 and Full Year 2024 Earnings Call on January 29, 2025
T-Mobile US, Inc. (NASDAQ: TMUS) looks forward to discussing fourth quarter and full year 2024 financial and operational results on Wednesday, January 29, 2025, at 8:00 a.m. Eastern Time (ET). The
T-Mobile to Host Q4 and Full Year 2024 Earnings Call on January 29, 2025
T-Mobile US, Inc. (NASDAQ: TMUS) looks forward to discussing fourth quarter and full year 2024 financial and operational results on Wednesday, January 29, 2025, at 8:00 a.m. Eastern Time (ET). The
Discover Financial Services Announces Fourth Quarter 2024 Earnings Release on January 22, 2025, and Conference Call on January 23, 2025
Discover Financial Services (NYSE: DFS) plans to report its Fourth quarter 2024 results after the market closes on Wednesday, January 22, 2025. The earnings release will be available through
Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc
Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc
Trane Technologies Named to S&P Dow Jones Sustainability World and North America Indices
Trane Technologies (NYSE:TT), a global climate innovator, has been named to the S&P Dow Jones Sustainability World Index for the fourth consecutive year and the North America Index for the
Mettler-Toledo International Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Mettler-Toledo International Inc. (NYSE: MTD) today announced it will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 14, 2025 at 3:45 p.m
U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and mFOLFOX6
U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and mFOLFOX6
Humana Names Japan Mehta as Chief Information Officer
Leading health and well-being company Humana Inc. (NYSE: HUM) announced today that it has named Japan Mehta as Chief Information Officer. In this role, Mehta will oversee Humana’s digital and
State Street Corporation Declares Common Stock Dividend
State Street Corporation (NYSE: STT) today announced a quarterly cash dividend of $0.76 per share of common stock, payable on January 13, 2025 to common shareholders of record at the close of
UDR Declares Quarterly Dividends
UDR, Inc. (NYSE: UDR), a leading multifamily real estate investment trust, today announced that its Board of Directors declared a regular quarterly dividend on its common stock for the fourth
Eaton names Lucy Clark Dougherty general counsel; Taras “Terry” Szmagala Jr. to retire
Intelligent power management company Eaton (NYSE:ETN) today announced that Lucy Clark Dougherty has been named general counsel, effective January 27, 2025. Dougherty will succeed Taras “Terry”
IFF Announces Board of Directors Changes
IFF (NYSE: IFF) today unveiled the next phase in the evolution of its Board of Directors, aimed at bolstering the company's long-term strategic vision and driving profitable market share growth.
NIKE, Inc. Reports Fiscal 2025 Second Quarter Results
NIKE, Inc. (NYSE:NKE) today reported fiscal 2025 financial results for its second quarter ended November 30, 2024.
-
Second quarter revenues were $12.4 billion, down 8 percent on a reported basis
NIKE, Inc. Reports Fiscal 2025 Second Quarter Results
NIKE, Inc. (NYSE:NKE) today reported fiscal 2025 financial results for its second quarter ended November 30, 2024.
-
Second quarter revenues were $12.4 billion, down 8 percent on a reported basis
Tennessee Gas Pipeline Announces Final Investment Decision on Mississippi Crossing Project
Tennessee Gas Pipeline, L.L.C. (TGP), a subsidiary of Kinder Morgan, Inc. (NYSE: KMI), today announced its decision to proceed with its Mississippi Crossing Project (MSX Project) after securing
ClinChoice verlängert 13-jährige Partnerschaft mit Medidata – Ergänzung von Clinical Data Studio zur Optimierung des Datenmanagements und Stärkung der Fähigkeiten im Bereich klinischer Studien
Medidata, eine Marke von Dassault Systèmes und führender Anbieter von Lösungen für klinische Studien in der Life-Science-Branche, erneuert seine langjährige Unternehmenspartnerschaft mit dem
ClinChoice verlängert 13-jährige Partnerschaft mit Medidata – Ergänzung von Clinical Data Studio zur Optimierung des Datenmanagements und Stärkung der Fähigkeiten im Bereich klinischer Studien
Medidata, eine Marke von Dassault Systèmes und führender Anbieter von Lösungen für klinische Studien in der Life-Science-Branche, erneuert seine langjährige Unternehmenspartnerschaft mit dem
Agilent to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Bob McMahon will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday
Pfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with Analysts
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:30 a.m. EST on Tuesday, February 4, 2025. The
Pfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with Analysts
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:30 a.m. EST on Tuesday, February 4, 2025. The
Texas A&M University-Mays Business School and Humana Announce Winners of Eighth Annual Healthcare Analytics Case Competition
Mays Business School at Texas A&M University and leading health and well-being company Humana Inc. (NYSE: HUM) are pleased to announce the winners of the 2024 Humana-Mays Healthcare Analytics Case
State Street Announces Three Additional Bank Partnerships to Support Minority Depository Institutions and Community Development Financial Institutions
State Street Corporation (NYSE: STT) today announced that it has placed an additional round of deposits through three Minority Depository Institutions (MDIs) and Community Development Financial
Schwab Announces Its Winter Business Update
The Charles Schwab Corporation announced today that it has scheduled a Winter Business Update for institutional investors on Tuesday, January 21st. This Update, which will be held via live public




